[1]
“The systemic factors of mitigating the contribution of the reversible phenotypic transitions of malignant cells to therapeutic resistance”, Вопр. онкол., vol. 68, no. 6, pp. 708–716, Dec. 2022, doi: 10.37469/0507-3758-2022-68-6-708-716.